Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Total Current Liabilities (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Total Current Liabilities for 3 consecutive years, with $42.9 million as the latest value for Q1 2026.

  • Quarterly Total Current Liabilities rose 10.95% to $42.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $42.9 million through Jan 2026, up 10.95% year-over-year, with the annual reading at $38.0 million for FY2025, 15.18% up from the prior year.
  • Total Current Liabilities for Q1 2026 was $42.9 million at Kestra Medical Technologies, up from $35.8 million in the prior quarter.
  • The five-year high for Total Current Liabilities was $42.9 million in Q1 2026, with the low at $32.3 million in Q3 2025.
  • Average Total Current Liabilities over 3 years is $36.8 million, with a median of $36.9 million recorded in 2025.
  • The sharpest move saw Total Current Liabilities rose 15.18% in 2025, then rose 10.95% in 2026.
  • Over 3 years, Total Current Liabilities stood at $33.0 million in 2024, then increased by 8.45% to $35.8 million in 2025, then grew by 20.07% to $42.9 million in 2026.
  • According to Business Quant data, Total Current Liabilities over the past three periods came in at $42.9 million, $35.8 million, and $32.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.